Slingshot Insights | Aavxf Overview

AAVXF Overview

Upcoming Projects (AAVXF)

Analyzing Phase 3 ABTECT Induction Trial Results for Obefazimod in Moderate to Severely Active Ulcerative Colitis from Abivax
Ticker: AAVXF
Execute By: Dec 31, 2025
Comparing late 2025 ulcerative colitis data across Eli Lilly’s mirikizumab (Omvoh), Abivax’s obefazimod, and Protagonist Therapeutics’ icotrokinra: evolving standards in long-term and oral IL-23 pathway–targeted therapy
Tickers: LLY, AAVXF, PTGX
Execute By: Oct 21, 2026

Upcoming & Overdue Catalysts (AAVXF)

Don’t see a catalyst related to the company you care about? Create your own!

Strategic Initiatives (AAVXF)

Don’t see a strategic initiative related to the company you care about? Create your own!